A Prospective Study Evaluating the Performance of Nanotite Osseotite Implants When Placed by Graduate Student Programs
CollegeBowl
A Prospective Randomized-controlled Evaluation of Nanotite and Osseotite Surfaced Implant Performance in Graduate Student Programs
1 other identifier
interventional
241
1 country
1
Brief Summary
This study will evaluate the contributions of the Nanotite implant design when used by graduate students in their first year of placing implants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 29, 2008
CompletedFirst Posted
Study publicly available on registry
July 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedResults Posted
Study results publicly available
February 12, 2014
CompletedMarch 28, 2022
March 1, 2022
4.5 years
July 29, 2008
November 19, 2013
March 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Integration Success of the Implant
1 year
Study Arms (2)
Nanotite implant
EXPERIMENTALNanotite dental implant
Osseotite implant
ACTIVE COMPARATOROsseotite dental implant
Interventions
Nanotite root form titanium dental implant
Osseotite Root form titanium dental implant
Eligibility Criteria
You may qualify if:
- patients of either sex and of any race, 18 years of age or older
- patients for whom a decision has already been made to use dental implants for treating edentulism in the mandible or maxilla
You may not qualify if:
- patients who are known to be pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ZimVielead
Study Sites (1)
University of Alabama Birmingham
Birmingham, Alabama, 35294, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Research Manager
- Organization
- Biomet 3i LLC
Study Officials
- PRINCIPAL INVESTIGATOR
Michael S Reddy, DMD
University of Alabama at Birmingham
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2008
First Posted
July 31, 2008
Study Start
April 1, 2008
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
March 28, 2022
Results First Posted
February 12, 2014
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share